510(k) Report

FDA product code · Cardiovascular

Implantable Pulse Generator

QFVClass IIIPMA required1 decision since 20190 recalls

1 FDA decision since 2019. No recall names this code.

Deliver Cardiac Contractility Modulation signals during the absolute refractory period

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026 Download the data (CSV)

FIG. A — Illustration, cardiovascular panel

Twenty years of QFV at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.

FDA decisions per year · QFV

5in 2025

2019: 42020: 32021: 42022: 52023: 92024: 102025: 52026 (partial year): 4
2007high 10 (2024) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QFV

Too few QFV 510(k)s in any year since 2007 to give a median.

Recalls per year · QFV

No recall names QFV since 2007.

Adverse event reports per year · QFV

31in 2025

2020: 12022: 12023: 242024: 452025: 31
2007high 45 (2024) · low 0 (2007)2025

MAUDE reports naming product code QFV, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20194—00
20203—01
20214—00
20225—01
20239—024
202410—045
20255—031
20264—0—
FIG. 1 — QFV by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports, MAUDE · Data through Oct 25, 2026

Planning a device in QFV? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report